Nicole Christina Riddle

Nicole Christina Riddle

Auto-generated profile, based on publicly available information

Nicole Christina Riddle

Department of Biology, University of Alabama at Birmingham, Birmingham, USA

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2005 in Trends in Genetics
Verified
Journal Article
Closed access
JBJames Birchler
James Birchler
NRNicole C. Riddle
Nicole C. Riddle
DADonald L. Auger
Donald L. Auger
RVReiner A. Veitia
Reiner A. Veitia

1 November 2003 in Trends in Genetics
Verified
Journal Article
Closed access
NRNicole C. Riddle
Nicole C. Riddle
JBJames A. Birchler
James A. Birchler

23 January 2022 in Aging Cell
Verified
Journal Article
Open access
PDF file
ABAnne M. Bronikowski
Anne M. Bronikowski
RMRichard P. Meisel
Richard P. Meisel
PBPeggy R. Biga
Peggy R. Biga
JWJames R. Walters
James R. Walters
JMJudith Mank
Judith Mank
NRNicole C. Riddle
Nicole C. Riddle
Sex differences in aging occur in many animal species, and they include sex differences in lifespan, in the onset and progression of age‐associated decline, and in physiological and molecular markers of aging. Sex differences in aging vary greatly across the animal kingdom. For example, there are species with longer‐lived females, species where males live longer, and species lacking sex differences in lifespan. The underlying causes of sex differences in aging remain mostly unknown. Currently, we do not understand the molecular drivers of sex differences in aging, or whether they are related to the accepted hallmarks or pillars of aging or linked to other well‐characterized processes. In particular, understanding the role of sex‐determination mechanisms and sex differences in aging is relatively understudied. Here, we take a comparative, interdisciplinary approach to explore various hypotheses about how sex differences in aging arise. We discuss genomic, morphological, and environmental differences between the sexes and how these relate to sex differences in aging. Finally, we present some suggestions for future research in this area and provide recommendations for promising experimental designs.

2 June 2017 in The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences
Verified
Journal Article
Open access
PDF file
KFKathleen E Fischer
Kathleen E Fischer
NRNicole C Riddle
Nicole C Riddle
Aging is characterized by decreasing physiological integration, reduced function, loss of resilience, and increased risk of death. Paradoxically, although women live longer, they suffer greater morbidity particularly late in life. These sex differences in human lifespan and healthspan are consistently observed in all countries and during every era for which reliable data exist. While these differences are ubiquitous in humans, evidence of sex differences in longevity and health for other species is more equivocal. Among fruit flies, nematodes, and mice, sex differences in lifespan vary depending on strain and treatment. In this review, we focus on sex differences in age-related alterations in DNA damage and mutation rates, telomere attrition, epigenetics, and nuclear architecture. We find that robust sex differences exist, eg, the higher incidence of DNA damage in men compared to women, but sex differences are not often conserved between species. For most mechanisms reviewed here, there are insufficient data to make a clear determination regarding the impact of sex, largely because sex differences have not been analyzed. Overall, our findings reveal an urgent need for well-designed studies that explicitly examine sex differences in molecular drivers of aging.

27 January 2016 in The Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
EGErik G. Gentry
Erik G. Gentry
BHBenjamin W. Henderson
Benjamin W. Henderson
AAAndrew E. Arrant
Andrew E. Arrant
MGMarla Gearing
Marla Gearing
YFYangbo Feng
Yangbo Feng
JHJeremy H. Herskowitz
Jeremy H. Herskowitz
Progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) are neurodegenerative four-repeat tauopathies with no cure. Mitigating pathogenic tau levels is a rational strategy for tauopathy treatment, but therapeutic targets with clinically available drugs are lacking. Here, we report that protein levels of the Rho-associated protein kinases (ROCK1 and ROCK2), p70 S6 kinase (S6K), and mammalian target of rapamycin (mTOR) were increased in PSP and CBD brains. RNAi depletion of ROCK1 or ROCK2 reduced tau mRNA and protein level in human neuroblastoma cells. However, additional phenotypes were observed under ROCK2 knockdown, including decreased S6K and phosphorylated mTOR levels. Pharmacologic inhibition of Rho kinases in neurons diminished detergent-soluble and -insoluble tau through a combination of autophagy enhancement and tau mRNA reduction. Fasudil, a clinically approved ROCK inhibitor, suppressed rough eye phenotype and mitigated pathogenic tau levels by inducing autophagic pathways in aDrosophilamodel of tauopathy. Collectively, these findings highlight the Rho kinases as rational therapeutic targets to combat tau accumulation in PSP and CBD.SIGNIFICANCE STATEMENTStudies of progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) suggest that mitigating pathogenic tau levels is a rational strategy for tauopathy treatment. In this report, the Rho-associated protein kinases (ROCK1 and ROCK2) are identified as novel drug targets for PSP and CBD. We show that elevated insoluble tau levels are associated with increased ROCK1 and ROCK2 in PSP and CBD brains, whereas experiments in cellular and animal models identify pharmacologic inhibition of ROCKs as a mechanism-based approach to reduce tau levels. Our study correlates bona fide changes in PSP and CBD brains with cellular models, identifies drug targets, and tests the therapeuticin vivo.

20 October 2006 in Theoretical and Applied Genetics
Verified
Journal Article
Closed access
PDF file
NRNicole C. Riddle
Nicole C. Riddle
AKAkio Kato
Akio Kato
JBJames Birchler
James Birchler